World Antimicrobial Resistance Awareness Week 2024: Educate. Advocate. Act Now.
Antimicrobial resistance (AMR) is a critical and growing global health threat affecting humans, animals, and the environment. As bacteria, viruses, fungi, and parasites develop resistance to existing treatments, infections become harder to treat, leading to a greater risk of disease spread, severe illness, and death. Tackling AMR requires raising awareness, promoting the responsible use of antibiotics, and strengthening systems in healthcare, agriculture, and environmental management to reduce the emergence and spread of drug-resistant pathogens. Through collective global action, we can protect the efficacy of essential medicines for generations to come.
In recognition of World Antimicrobial Resistance Awareness Week (18–24 November 2024), we invite you to explore selected articles, Special Issues, and journals that span fields such as medicine, pharmacology, biology, and life sciences. By sharing this knowledge, we aim to inspire positive action and foster collaboration to mitigate AMR’s impact, ultimately supporting a healthier, more sustainable future for all.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
MDPI World Antimicrobial Resistance Awareness Week 2024 Webinar
22 November 2024, 15:00 (CET)
Free to register for this webinar!
Recordings will be available on Sciforum shortly afterwards.
“Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens”
by Yosra A. Helmy, Khaled Taha-Abdelaziz, Hanan Abd El-Halim Hawwas, Soumya Ghosh, Samar Sami AlKafaas, Mohamed M. M. Moawad, Essa M. Saied, Issmat I. Kassem and Asmaa M. M. Mawad
Antibiotics 2023, 12(2), 274; https://doi.org/10.3390/antibiotics12020274
“Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID”
by Aristo Vojdani, Elroy Vojdani, Evan Saidara and Michael Maes
Viruses 2023, 15(2), 400; https://doi.org/10.3390/v15020400
“Photomodulation Approaches to Overcome Antimicrobial Resistance”
by Sofia N. Sarabando, Andreia Palmeira, Maria Emília Sousa, Maria Amparo F. Faustino and Carlos J. P. Monteiro
Pharmaceuticals 2023, 16(5), 682; https://doi.org/10.3390/ph16050682
“Antimicrobial Nanoformulations Based on Schinus areira Essential Oil”
by Andrea C. Cutro, Anike Ferreyra Maillard, Pablo R. Dalmasso, Sergio A. Rodriguez and Axel Hollmann
Drugs Drug Candidates 2023, 2(2), 498–515; https://doi.org/10.3390/ddc2020026
“Inappropriate Prescribing of Antibiotics to Pediatric Patients Receiving Medicaid: Comparison of High-Volume and Non-High-Volume Antibiotic Prescribers—Kentucky, 2019”
by Bethany A. Wattles, Michael J. Smith, Yana Feygin, Kahir Jawad, Andrea Flinchum, Brittany Corley and Kevin B. Spicer
Healthcare 2023, 11(16), 2307; https://doi.org/10.3390/healthcare11162307
“Modulation of Staphylococcus aureus Biofilm Formation through Subinhibitory Concentrations of Biogenic Silver Nanoparticles and Simvastatin”
by Ana Carolina Furian da Silva, Sindy Magri Roque, Marta Cristina Teixeira Duarte, Gerson Nakazato, Nelson Durán and Karina Cogo-Müller
Future Pharmacol. 2024, 4(1), 3–16; https://doi.org/10.3390/futurepharmacol4010002
“Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance”
by Francesco Ferrara, Roberta Pasquinucci, Maurizio Capuozzo, Giacomo Polito, Gabriele Bagaglini, Marcello Vaccaro, Adriana Coluccia, Roberto Langella, Ugo Trama, Eduardo Nava et al.
Pharmaceuticals 2024, 17(2), 183; https://doi.org/10.3390/ph17020183
“Influence of Organic Matter from Native Fish on the Antimicrobial Efficacy of Sodium Hypochlorite (NaClO) in Reducing Salmonella spp. Population”
by Jaqueline Oliveira Reis, Carine Baggio Cavalcante, Nathaly Barros Nunes, Adelino Cunha Neto, Maxsueli Aparecida Moura Machado, Yuri Duarte Porto, Vinicius Silva Castro and Eduardo Eustáquio de Souza Figueiredo
Microbiol. Res. 2024, 15(1), 342–353; https://doi.org/10.3390/microbiolres15010023
“The Prevalence of Duplicate Prescription of Oral Antibiotic Drugs in Outpatient Care among People Insured by Corporate Health Insurance Societies in Japan”
by Kenichi Fujimoto and Shinichi Tanihara
Healthcare 2024, 12(11), 1150; https://doi.org/10.3390/healthcare12111150
“Design, Synthesis, and In Vitro Antimalarial Evaluation of New 1,3,5-Tris[(4-(Substituted-Aminomethyl)Phenoxy)Methyl]Benzenes”
by Sandra Albenque-Rubio, Jean Guillon, Patrice Agnamey, Céline Damiani, Solène Savrimoutou, Romain Musière, Noël Pinaud, Stéphane Moreau, Jean-Louis Mergny, Luisa Ronga et al.
Drugs Drug Candidates 2024, 3(3), 615–637; https://doi.org/10.3390/ddc3030035
| Topical Collection “Anti-Parasite Drug Discovery” | Special Issue “Antileishmanial Agents” |
 |
 |
|
Special Issue “New Approaches to Fighting Infectious Diseases: Overcoming the Antimicrobial Resistance in Current Treatments” |
|
 |
 |
 |
 |